SEER
Head of Investor Relations
Head of Investor Relations
Adaptive Biotechnologies Corp (ADPT)Head of Investor Relations
10x Genomics, Inc. (TXG)Head of Investor Relations
Guardant Health, Inc. (GH)Head of Investor Relations
Pacific Biosciences Of California, Inc. (PACB)Head of Investor Relations
908 Devices Inc. (MASS)Head of Investor Relations
Seer, Inc. (SEER)Head of Investor Relations
Nautilus Biotechnology, Inc. (NAUT)Head of Investor Relations
Ginkgo Bioworks Holdings, Inc. (DNA)Head of Investor Relations
SI-BONE, Inc. (SIBN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Carrie Mendivil is recorded as Head of Investor Relations at Adaptive Biotechnologies Corp (ADPT), Head of Investor Relations at 10x Genomics, Inc. (TXG), Head of Investor Relations at Guardant Health, Inc. (GH), Head of Investor Relations at Pacific Biosciences Of California, Inc. (PACB), Head of Investor Relations at 908 Devices Inc. (MASS), Head of Investor Relations at Seer, Inc. (SEER), Head of Investor Relations at Nautilus Biotechnology, Inc. (NAUT), Head of Investor Relations at Ginkgo Bioworks Holdings, Inc. (DNA) and Head of Investor Relations at SI-BONE, Inc. (SIBN). Carrie Mendivil has spoken on 29 earnings calls across 4 companies, most recently for Seer, Inc. on February 27, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Recorded roles and call appearances connecting this person to public companies.
SEER
Head of Investor Relations
Head of Investor Relations
Head of Investor Relations
MASS
Head of Investor Relations
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.